Takeda to import and distribute 50 million doses of Moderna’s COVID-19 vaccine in Japan
OSAKA: Takeda Pharmaceutical Company Limited will import and distribute 50 million doses of Moderna’s COVID-19 vaccine candidate, mRNA-1273, starting in the first half of 2021,...
Takeda assesses financial impact from Novartis’ withdrawal of marketing authorisation application for Xiidra
OSAKA: Takeda Pharmaceutical Company Limited announced the anticipated financial impact from Novartis Europharm Limited’s withdrawal of the Marketing Authorisation Application (MAA) for Xiidra in Europe,...